Hologic, Inc. (HOLX)
Apr 7, 2026 - HOLX was delisted (reason: acquired by Blackstone and TPG)
76.01
0.00 (0.00%)
Inactive · Last trade price on Apr 6, 2026

Hologic Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
4,1274,1014,0304,0304,8635,632
Revenue Growth
2.17%1.74%-0.00%-17.12%-13.66%49.15%
Gross Profit
2,3752,1182,2282,0722,9973,796
Operating Income
721.5714.3882.6668.41,6402,480
Net Income
543.8565.7789.54561,3021,872
Earnings Per Share
2.402.493.321.835.137.21
EPS Growth
-24.29%-25.00%81.42%-64.33%-28.85%71.26%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Breast Health
960.21,4841,5231,4331,2281,352
Diagnostics
1,2051,8271,7821,8803,0193,695
Skeletal Health
92.2109.484.1113.493.696.9
GYN Surgical
313.4679.8641.3604.2522.9488.1
Total
2,5714,1014,0304,0304,8635,632

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
2,3652,2032,3342,7232,3401,170
Total Debt
2,5202,5202,5502,8372,8453,052
Net Cash (Debt)
-155.6-317.7-216.5-114.1-505.1-1,881
Net Cash Growth
------
Net Cash Per Share
-0.69-1.40-0.91-0.46-1.99-7.24

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
1,0981,0571,2851,0512,1262,330
Capital Expenditures
-140.5-137-130.2-150.2-127.2-177.7
Free Cash Flow
957.2920.11,1559011,9992,153
Free Cash Flow Growth
-15.34%-20.34%28.19%-54.92%-7.16%190.83%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
57.54%51.65%55.28%51.40%61.64%67.39%
Operating Margin
17.48%17.42%21.90%16.58%33.73%44.04%
Pretax Margin
16.08%16.61%21.46%16.78%32.66%41.92%
Profit Margin
13.18%13.80%19.59%11.31%26.77%33.20%
FCF Margin
23.20%22.44%28.66%22.36%41.10%38.22%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PE Ratio
31.6326.9924.3437.9212.2810.61
Forward PE
16.7715.2118.8818.3820.3520.20
P/FCF Ratio
17.7316.2616.2118.627.799.01
PS Ratio
4.113.654.654.163.203.44